Time to Reschedule, President Laughy-Boy – part 2

by Patrick Devlin

A team of scientists from Canada, New Zealand, The United Kingdom and the United States has reported that even heavy users of cannabis have no greater chance of contracting lung cancer from their use of the substance than casual cannabis users or, remarkably, even non-cannabis users.

The study, which is to be published in the International Journal of Cancer, analyzed data from six case studies involving more than 5000 participants and found that there is “little evidence for an increased risk of lung cancer among habitual or long-term cannabis smokers.”

The review of research echoed previous medical studies, reported in the Annals of the American Thoracic Society in 2013, that revealed that “habitual use of marijuana alone does not appear to lead to significant abnormalities in lung function…Overall the risks of pulmonary complications of regular use of marijuana appear to be relatively small and far lower than those of tobacco smoking.”

The journal actually went further, as another article from 2013 posited that “cannabis smoking does not seem to increase risk of chronic obstructive pulmonary disease or airway cancers. In fact, there is even a suggestion that low doses (of) cannabis may be protective for both conditions.”

The findings support the conjecture of many in the medical community that cannabis contains “anti-cancer properties” including the ability to inhibit the growth of lung cancer tumors, but no studies have been performed on human subjects due in part to the embargo against researching the capacities of cannabis’ medical benefits as the substance is considered by law enforcement and the White House to be amongst the most dangerous illegal drugs, as dangerous and medically non-useful as LSD and peyote, but less safe less medically useful than methanphetamine, cocaine and synthetic heroin.

Comments are closed.